FDA Clearance Tracker · P150048
EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)
Last checked: Nov 19, 2026Latest source record: Jun 29, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 29, 2017
Approved
Time to decision
549 days
Received Dec 28, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150048
- Device name
- EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Dec 28, 2015
- Decided
- Jun 29, 2017
- Decision
- Approved
- Supplements
- 98 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the Edwards Pericardial Aortic Bioprosthesis and Edwards INSPIRIS RESILIA Aortic Valve. The Edwards Pericardial Aortic Bioprosthesis, Model 11000A, is indicated for the replacement of native or prosthetic aortic heart valves. The Edwards INSPIRIS RESILIA Aortic Valve, Model 11500A, is indicated for the replacement of native or prosthetic aortic heart valves.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LWR. The earliest in FDA's data is P790007, decided Nov 15, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
P260007 · Decided Oct 1, 2026 · 234 days after receipt
Device type: Heart-valve, polymeric (SJL) · Cardiology
K251326 · Decided Jun 11, 2026 · 408 days after receipt
Device type: Monitor, Breathing Frequency (BZQ) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.